# A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab

> **NCT04537429** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 28 (actual)

## Conditions studied

- Migraine in Children
- Migraine

## Interventions

- **DRUG:** Eptinezumab

## Key facts

- **NCT ID:** NCT04537429
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-04
- **Primary completion:** 2022-10-20
- **Final completion:** 2023-08-21
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04537429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04537429, "A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04537429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*